Citigroup
ENZN

Citigroup’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Citigroup’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-43
Closed – – 8079
2015
Q4 		$0 Sell
43
-5
-10% -$4 ﹤0.01% 8157
2015
Q3 		$0 Buy
+48
New +$59 ﹤0.01% 8120
2015
Q1 		– Sell
-287
Closed – – 7653
2014
Q4 		$0 Sell
287
-47
-14% -$49 ﹤0.01% 7518
2014
Q3 		$0 Buy
+334
New +$412 ﹤0.01% 7494
2014
Q2 		– Sell
-10,073
Closed -$11K – 7498
2014
Q1 		$11K Sell
10,073
-16,317
-62% -$16.9K ﹤0.01% 6317
2013
Q4 		$31K Buy
26,390
+6,466
+32% +$9.96K ﹤0.01% 5968
2013
Q3 		$34K Sell
19,924
-1,196
-6% -$2.21K ﹤0.01% 5571
2013
Q2 		$42K Buy
+21,120
New +$61.8K ﹤0.01% 5479

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Citigroup's ENZN Position: Q1 2016 in Review

Citigroup sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q1 2016, closing a stake of 43 shares.

Citigroup first reported a position in ENZN in Q2 2013 and held it in 8 quarters. The position peaked at $42K in Q2 2013. 40 funds tracked by Wall St. Rank hold ENZN as of Q1 2016.

  • Citigroup reported no remaining ENZON PHARMACEUTICALS INC position as of Q1 2016 after selling out during the quarter.
  • Citigroup sold 43 ENZON PHARMACEUTICALS INC shares in Q1 2016.
  • Citigroup first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 8 quarters.
  • Citigroup's ENZON PHARMACEUTICALS INC position peaked at $42K in Q2 2013.
  • 40 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q1 2016.

Based on Citigroup's 13F filing for Q1 2016, filed 13 May 2016.